Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Apidra (insulin glulisine) - Important Safety Information from Sanofi-Aventis as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
31/01/2012
Problem Or Issue:
Important Safety Information from Sanofi-Aventis regarding a temporary supply shortage of Apidra (insulin glulisine) [rDNA origin] cartridges for injection affecting: Apidra 3ml Cartridges, Apidra SoloStar and Apidra OptiSet in Ireland.
Important Safety Information - Apidra
« Back
Date Printed: 20/05/2024